Drug-Makers on Vanguard Level- Biodel (NASDAQ:BIOD), Pernix Therapeutics (NASDAQ:PTX)
Thursday bloom on Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) [Trend Analysis], stock build up around 4.36% in early session as its gaining volume of 27.11 Million. Pernix Therapeutics Holdings, Inc. (PTX) released that U.S. Patent and Trademark Office has issued U.S. Patent Numbers 9,339,499 (‘499 patent), 9,326,982, and 9,333,201 (‘201 patent), covering important safety information related to dosing patients with Zohydro ER with BeadTek.
These patents, in addition to the 9,265,760 patent (‘760 patent) which issued February 23, 2016, are broadly directed to a method of dosing patients with hepatic impairment with hydrocodone where no adjustment in start dose is needed for patients with mild or moderate hepatic impairment. The ‘760, ‘499, ‘982 and ‘201 patents expire July 25, 2033.
“The ‘499, ‘982, and the ‘201 patents, solely owned by Pernix, are a significant addition to the Orange Book, bringing the total number of Orange Book listed patents covering Zohydro ER with BeadTek to seven,” said John Sedor, Chairman and Interim CEO of Pernix Therapeutics. “We continue to invest in this brand and currently have a half dozen more patent applications pending relating to Zohydro ER with BeadTek.”
In order for a generic drug manufacturer to win approval of a drug under the Hatch-Waxman Act, the generic manufacturer must certify that they will not launch their generic until after the expiration of the Orange Book-listed patent, or that the patent is invalid, unenforceable, or that the generic product will not infringe the listed patent.
I realize that this is SPAM. Having said that, I would like to mention that CNBC is comprised of the most idiots and clueless individuals imaginable. I would not listen to their advice and feel comfortable doing the opposite of what they usually recommend. Recently they huge were Perma Bears predicting that the sky was falling and this resulted in a monstrous market turnaround.
Jim Cramer is a nut.
Nothing out of the ordinary will take place as is stated and reaffirmed in the announcement. Only the business outlined in the notice is on the agenda. Do not expect anything to transpire beyond what is already public information.
That dumbbell asianshorts is reading the messages here, so if you have anything to say directed to him then say it. I am glad that distracting nut case is actively gone from this message board. if he had spent as much time buying shares long as he did bashing the other investors here, he would have profited handsomely.
As of March 31, 2016, there were outstanding warrants to purchase 1,974,842 shares of our common stock. The warrants contain customary anti-dilution and net issuance provisions and are not callable by us.
Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws
Some provisions of Delaware law, our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that could make the following transactions more difficult: an acquisition of us by means of a tender offer; an acquisition of us by means of a proxy contest or otherwise; or the removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions which provide for payment of a premium over the market price for our shares.
These provisions, summarized below, are intended to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of the increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.